Effect of pyroglutamic acid stereoisomers on ecs and scopolamine-induced memory disruption and brain acetylcholine levels in the rat
- 1 December 1987
- journal article
- Published by Elsevier BV in Pharmacological Research Communications
- Vol. 19 (12), 901-912
- https://doi.org/10.1016/0031-6989(87)90040-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cognitive Improvement in Clinical Trials with Nootropic DrugsClinical Neuropharmacology, 1986
- Experimental Behavioral Studies with Oxiracetam on Different Types of Chronic Cerebral ImpairmentClinical Neuropharmacology, 1986
- Pyroglutamic acid administration modifies the electrocorticogram and increases the release of acetylcholine and gaba from the guinea-pig cerebral cortexPharmacological Research Communications, 1984
- Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacologyEuropean Journal of Clinical Pharmacology, 1984
- Piracetam in elderly psychiatric patients with mild diffuse cerebral impairmentPsychopharmacology, 1983
- Is acetylcholine release from striatal nerve endings regulated by muscarinic autoreceptors?European Journal of Pharmacology, 1983
- Lesions of cholinergic forebrain nuclei: Changes in avoidance behavior and scopolamine actionsPharmacology Biochemistry and Behavior, 1982
- Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodentsPsychopharmacology, 1982
- Human Memory and the Cholinergic SystemArchives of Neurology, 1974
- Atropine, scopolamine, and Ditran: Comparative pharmacology and antagonists in manPsychopharmacology, 1973